Kenvue Inc. (KVUE) Stock Score, Valuation & Financial Research
Kenvue Inc. is in the Consumer Defensive sector and Household & Personal Products industry. It is reviewed using Wall Street Score's company-strength, valuation, growth and financial-health framework. The current Wall Street Score is 34/100.
Quick answer for KVUE
Kenvue Inc. currently has a Wall Street Score of 34/100. The stored market price is $17.78. Its financial score is 30/100. Its valuation score is 16/100. These figures are a research snapshot, not a buy or sell recommendation.
What Kenvue Inc. does
Kenvue Inc. functions as a global leader in the consumer health sector. The company structures its operations across three primary divisions: Self Care, Skin Health and Beauty, and Essential Health. Within the Self Care unit, it offers a diverse range of products for common conditions like coughs, colds, and allergies, in addition to pain relief, digestive health, and smoking cessation aids, featuring prominent brands such as Tylenol, Nicorette, and Zyrtec. The Skin Health and Beauty segment delivers various solutions for facial, body, hair, and sun protection, recognized under popular labels including Neutrogena, Aveeno, and OGX. Moreover, the Essential Health category provides oral hygiene, infant care, feminine wellness, and wound treatment products, marketed through esteemed brands like Listerine, Johnson's, Band-Aid, and Stayfree. Established in 2022, Kenvue Inc. maintains its corpo
KVUE financial snapshot
- Wall Street Score:
- 34/100
- Current price:
- $17.78
- Market capitalization:
- $34.14B
- Revenue:
- $15.29B
- Net income:
- $1.62B
- Free cash flow:
- $1.72B
- Cash:
- $1.07B
- Total debt:
- $8.66B
- EPS:
- 0.77
- P/E ratio:
- 23.1x
- Financial score:
- 30/100
- Valuation score:
- 16/100
- Revenue score:
- 14/100
What stands out
- Reported year-over-year revenue growth is +0.0%.
- Free cash flow is $1.72B, showing positive cash generation.
- The balance sheet shows $1.07B of cash versus $8.66B of total debt, so leverage deserves attention.
What the numbers mean
Its current valuation score is 16/100, which Wall Street Score classifies as weak within the model's valuation framework.
The financial score is 30/100. This is a starting point for reviewing liquidity, leverage and cash-flow strength rather than a stand-alone recommendation.
A strong company and an attractive stock price are not always the same thing. Revenue, earnings, free cash flow, debt, management quality, competitive advantage and valuation should be considered together. Wall Street Score organizes these inputs into a consistent research framework so investors can identify what deserves deeper review.
Data freshness: Financial data last refreshed 2026-07-24.
How to research KVUE
Start by understanding how the company makes money. Then compare revenue and earnings trends, cash generation, debt, liquidity and valuation. Review the company's latest filings and earnings reports before acting on any score or model estimate.
Learn how to analyze a stock · Read the Wall Street Score methodology · Browse other stocks
Data may change as company filings and market prices update. Educational research only; not a buy or sell recommendation.